| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total | 
| 19/10/2021 | FH8023 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 276 | 0 | 0 | 0 | 0 | 276 | 
| 21/10/2021 | 219VCD28DW | Fiocruz/Oxford/AstraZeneca | 0 | 305 | 0 | 0 | 0 | 305 | 
| 21/10/2021 | 31065BD | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 297 | 0 | 0 | 0 | 594 | 
| 26/10/2021 | 31065BD | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 66 | 0 | 0 | 0 | 66 | 
| 29/10/2021 | FG3535 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 246 | 
| 03/11/2021 | FH4750 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 402 | 0 | 0 | 0 | 402 | 
| 04/11/2021 | FJ2594 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 300 | 0 | 0 | 0 | 0 | 600 | 
| 09/11/2021 | FJ2594 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 150 | 0 | 0 | 0 | 300 | 
| 17/11/2021 | FL7476 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 312 | 0 | 0 | 0 | 312 | 
| 17/11/2021 | FL1939 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 48 | 
| 18/11/2021 | FL1939 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 264 | 264 | 0 | 0 | 0 | 528 | 
| 22/11/2021 | 219VCD288Z | Fiocruz/Oxford/AstraZeneca | 0 | 100 | 0 | 0 | 0 | 100 | 
| 22/11/2021 | FM3802 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 408 | 0 | 0 | 0 | 408 | 
| 25/11/2021 | FM3884 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 192 | 192 | 0 | 0 | 0 | 384 | 
| 10/12/2021 | 1855836 | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 25 | 
| 10/12/2021 | 1855836 | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 25 | 
| 14/12/2021 | 204H21A | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 125 | 
| 20/12/2021 | 219VCD280W | Fiocruz/Oxford/AstraZeneca | 0 | 30 | 0 | 0 | 0 | 30 | 
| 20/12/2021 | FL5729 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 30 | 30 | 0 | 0 | 0 | 120 | 
| 27/12/2021 | FM3457 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 52 | 53 | 0 | 0 | 0 | 210 | 
| 03/01/2022 | FM3884 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 300 | 
| 10/01/2022 | FL4222 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 354 | 
| 15/01/2022 | FP1176 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 80 | 0 | 0 | 0 | 0 | 80 | 
| 17/01/2022 | 205F21A | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 60 | 
| 18/01/2022 | FP8290 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 80 | 0 | 0 | 0 | 0 | 80 | 
| 18/01/2022 | FL3196 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 99 | 99 | 0 | 0 | 0 | 396 | 
| 24/01/2022 | FM2951 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 366 | 
| 26/01/2022 | FP8290 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 120 | 0 | 0 | 0 | 0 | 120 | 
| 26/01/2022 | B202106074 | Butantan/CoronaVac | 49 | 0 | 0 | 0 | 0 | 49 | 
| 31/01/2022 | FM2967 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 246 | 0 | 0 | 0 | 246 |